Govt imposes export curbs on syringes to discourage outbound shipments
New Delhi: The government on Monday announced imposing export curbs on syringes with immediate effect, a move aimed at discouraging outbound shipments of the product in view of the present Covid-19 pandemic situation.
The directorate general of foreign trade (DGFT) in a notification said it has moved syringes export in the restricted category, under which an exporter has to seek a licence or government permission for the shipments.
"The export of syringes with or without needles...has been put under the restricted category with immediate effect," it said.
In 2020-21, the export of syringes stood at USD 45.68 million. It was USD 17.37 million during April-July this fiscal.
As per the DGFT the procedure for submission and approval of application for export of syringes will be notified separately, reports PTI.
In a separate public notice, the DGFT said the quantity of 5,841 tonnes of sugar (raw and/or white sugar) to be exported to the European Union (EU) under TRQ scheme from October 1, to September 30, 2022 has been notified.
TRQ (Tariff-Rate Quota) is for a volume of exports that enter the UK at relatively low tariffs. After the quota is reached, a higher tariff applies to the exports.
In August, the government had imposed restrictions on export of COVID-19 rapid antigen testing kits amid several experts warning of a possible third wave of the coronavirus pandemic.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.